Figure 4From: Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomasComparison of serum antibody levels among deletion mutants of SH3GL1. To confirm the epitope site, some SH3GL1 deletion mutants (A) were synthesized. Serum antibody levels were examined by ELISA with SH3GL1 muta-1 (B), mut-2 (C), mut-3 (D) and mut-4 (E), and the 10–20 amino acids at the C-terminal end were indicated as the epitope site.Back to article page